Johnson & Johnson Offers $5.5bn to Settle Baby Powder Lawsuits
The healthcare giant proposes a settlement to resolve tens of thousands of claims alleging its talc-based products caused ovarian cancer.
Trust 42Craft 55Hype 15How this was reported ▾
Single named source with direct quotes but no independent corroboration.
How well corroborated and evidenced the reporting is. Higher is better.
Clear facts and quotes but lacks affected parties or local context.
Context, balance and separation of fact from comment. Higher is better.
Headline proportionate to the substance of the story.
How far presentation runs ahead of substance. Lower is better.
1 source assessed · methodology
Johnson & Johnson (J&J) has put forward a proposal of up to $5.5bn (£4.14bn) to resolve tens of thousands of legal cases in the United States. These cases allege that the company's baby powder and other products containing talcum led to ovarian cancer. The proposed resolution aims to conclude a protracted legal dispute that has impacted the New Jersey-based healthcare firm for several years.
J&J has consistently denied that its talc-based products are responsible for causing cancer. The company has also altered the formulation of its widely used baby powder. Erik Haas, the firm's vice president of litigation, stated on Monday that the allegations are unfounded and that J&J is willing to settle to bring the matter to a close. The company is confident it would have prevailed in further legal proceedings, as it has in most cases heard to date, according to Haas.
Scope of the Proposed Settlement
Sunseeker Holiday Homes enters administration
The Hull-based manufacturer, founded in 2019, has appointed administrators, putting 76 jobs at risk.
The proposed settlement is intended to cover approximately 76,000 cases, representing the majority of outstanding claims related to talc. J&J indicated it would offer up to $3bn in the coming year, with no further payments scheduled before 2028. For the proposal to be finalised, it requires acceptance from legal representatives of 95% of the ovarian cancer claims filed in both state and federal courts, as reported by the BBC.
Haas added that this proposed resolution would allow the company to move past this issue and concentrate on its objective of developing treatments and devices that save lives. J&J's former consumer health division, Kenvue, which was spun off in 2022, holds responsibility for Johnson's baby powder sales outside of North America. Lawsuits concerning J&J's talc-based baby powder date back to 2009.
Background on Talc and Allegations
Enfield Town Liveable Neighbourhood scheme paused pending review
Transport for London funding for next phase is on hold as council re-evaluates project elements.
Talc, a mineral composed of magnesium, silicon, oxygen, and hydrogen, is known for its smooth texture and is commonly used in baby powder. Lawsuits have been filed by consumers and their families who assert that J&J's talc products caused cancer due to potential contamination with asbestos. Asbestos is a material known to cause cancer and is often found in geological seams near where talc is mined. Johnson & Johnson has repeatedly refuted these claims, stating that studies show talc is safe, free from asbestos, and does not cause cancer.
In 2022, Johnson & Johnson announced its decision to cease the production and sale of its talc-based baby powder worldwide. This announcement followed the company's discontinuation of sales for the product in the United States more than two years prior. At the time, J&J stated that this transition to an all cornstarch-based baby powder portfolio was a commercial decision resulting from a global portfolio assessment.
Questions this report answers
+How much is Johnson & Johnson offering to settle the lawsuits?
Johnson & Johnson has proposed a settlement of up to $5.5bn (£4.14bn) to resolve tens of thousands of lawsuits. This amount is intended to cover approximately 76,000 cases, representing the majority of outstanding claims related to talc-based products.
+What does Johnson & Johnson say about the safety of its talc products?
Johnson & Johnson denies that its talc-based products cause cancer and states that studies show talc is safe and free from asbestos. The company has altered its baby powder formulation and insists the allegations are unfounded despite the legal disputes.
+When will Johnson & Johnson start paying the settlement?
Johnson & Johnson plans to offer up to $3bn in the coming year, with no further payments scheduled before 2028. The full proposal requires acceptance from legal representatives of 95% of the ovarian cancer claims to be finalised.
Barnet Press News Desk
This article was written at the Barnet Press news desk from the reporting of the outlets listed below it. Drafting is done by a language model under human editorial supervision — there is no reporter behind this byline, and we would rather say so than invent one.
How stories are produced and scoredWho runs Barnet PressCorrections
Barnet conditions
Loading live conditions…
More Coverage in World
Sunseeker Holiday Homes enters administration
Enfield Town Liveable Neighbourhood scheme paused pending review
